Cardinal Health (CAH) Tops Q3 EPS by 7c, Miss on Revenue; Reaffirms FY EPS Guidance at Bottom of Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cardinal Health (CAH) PT Raised to $78 at Evercore ISI
May 1, 2017 11:05 AM EDTEvercore ISI bumped its price target on Cardinal Health (NYSE: CAH) modestly to $78.00 (from $77.50) while maintaining a Outperform rating following Q1 results.
Analyst Ross Muken said while the company didn't have any new surprises, they view Pharma momentum as slightly above... More
Tigress Financial Partners Starts Cardinal Health (CAH) at Neutral
April 30, 2017 2:30 PM EDTTigress Financial Partners initiates coverage on Cardinal Health (NYSE: CAH) with a Neutral rating.
Analyst Ivan Feinseth says the company has "extremely low" Economic Operating Cash Flow and Economic Profit margin while acknowledging the company's strong revenue growth. He sees low margins... More
